NasdaqGM - Nasdaq Real Time Price USD

Avadel Pharmaceuticals plc (AVDL)

Compare
13.92 +0.68 (+5.14%)
At close: October 17 at 4:00 PM EDT
13.90 -0.02 (-0.14%)
After hours: October 17 at 5:16 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
95,149.00
27,963.00
--
--
22,334.00
--
Cost of Revenue
5,120.00
846.00
--
--
5,742.00
--
Gross Profit
90,029.00
27,117.00
--
--
16,592.00
--
Operating Expense
188,815.00
164,966.00
95,216.00
85,599.00
53,253.00
--
Operating Income
-98,786.00
-137,849.00
-95,216.00
-85,599.00
-36,661.00
--
Net Non Operating Interest Income Expense
-9,640.00
-9,886.00
-12,342.00
-9,942.00
-12,994.00
--
Other Income Expense
1,775.00
-13,042.00
-3,881.00
2,396.00
44,573.00
--
Pretax Income
-106,651.00
-160,777.00
-111,439.00
-93,145.00
-5,082.00
--
Tax Provision
-427.00
-501.00
26,025.00
-15,816.00
-12,110.00
--
Net Income Common Stockholders
-106,224.00
-160,276.00
-137,464.00
-77,329.00
7,028.00
--
Diluted NI Available to Com Stockholders
-106,224.00
-160,276.00
-137,464.00
-77,329.00
7,028.00
--
Basic EPS
-1.09
-2.00
-2.29
-1.32
0.13
--
Diluted EPS
-1.09
-2.00
-2.29
-1.32
0.13
--
Basic Average Shares
91,833.50
80,174.00
60,094.00
58,535.00
52,996.00
--
Diluted Average Shares
91,833.50
80,174.00
60,094.00
58,535.00
54,941.00
--
Total Operating Income as Reported
-98,786.00
-137,849.00
-98,561.00
-85,546.00
5,815.00
--
Total Expenses
193,935.00
165,812.00
95,216.00
85,599.00
58,995.00
--
Net Income from Continuing & Discontinued Operation
-106,224.00
-160,276.00
-137,464.00
-77,329.00
7,028.00
--
Normalized Income
-107,991.89
-147,273.13
-134,398.01
-79,318.16
-23,054.57
--
Interest Expense
9,640.00
9,886.00
12,342.00
9,942.00
12,994.00
--
Net Interest Income
-9,640.00
-9,886.00
-12,342.00
-9,942.00
-12,994.00
--
EBIT
-97,011.00
-150,891.00
-99,097.00
-83,203.00
7,912.00
--
EBITDA
-95,456.00
-149,125.00
-97,604.00
-82,388.00
9,602.00
--
Reconciled Cost of Revenue
5,120.00
846.00
--
--
4,458.00
--
Reconciled Depreciation
1,555.00
1,766.00
1,493.00
815.00
1,690.00
--
Net Income from Continuing Operation Net Minority Interest
-106,224.00
-160,276.00
-137,464.00
-77,329.00
7,028.00
--
Total Unusual Items Excluding Goodwill
1,775.00
-13,042.00
-3,881.00
2,396.00
41,209.00
--
Total Unusual Items
1,775.00
-13,042.00
-3,881.00
2,396.00
41,209.00
--
Normalized EBITDA
-97,231.00
-136,083.00
-93,723.00
-84,784.00
-31,607.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
7.11
-39.13
-815.01
406.84
11,126.43
--
12/31/2019 - 6/7/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers